Aurinia pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Aurinia pharmaceuticals Contact Number

Contact Us :: Aurinia Pharmaceuticals Inc. (AUPH)

Just Now Auriniapharma.com Show details

(250) 744-2487Aurinia Pharmaceuticals Inc. Address. Canada Aurinia Corporate Headquarters #1203-4464 Markham Street Victoria, BC V8Z 7X8 Canada. Telephone: +1 (250) 744-2487 Fax: +1 …

Category: Contact SupportShow more

Contacts :: Aurinia Pharmaceuticals Inc. (AUPH)

7 hours ago Ir.auriniapharma.com Show details

514-982-7555Computershare Trust Company of Canada Shareholder Services Dept. 100 University Avenue 9th Floor Toronto, ON M5J 2Y1 Canada T: +1-514-982-7555 [email protected]

Category: Contact SupportShow more

Aurinia Pharmaceuticals Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

(250) 744-2487Contact Email [email protected] Phone Number +1 (250) 744-2487. Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing

Founded: Jan 01, 2013
Location: Victoria, British Columbia

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. (AUPH)

9 hours ago Auriniapharma.com Show details

Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Read Press Release View All News August 17, 2021 • 6:05am EDT

Category: Contact NumberShow more

Company Information :: Aurinia Pharmaceuticals Inc. (AUPH)

8 hours ago Ir.auriniapharma.com Show details

Company Contact Aurinia Pharmaceuticals Inc. #1203-4464 Markham Street Victoria, BC V8Z 7X8

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. Profile

3 hours ago Sedar.com Show details

Aurinia Pharmaceuticals Inc. Mailing Address: #201-17873 106a Avenue Edmonton, Alberta T5S 1V8: Head Office Address: 1203 - 4464 Markham Street Victoria, British Columbia V8Z 7X8: Contact Name: Joe Miller: Principal Regulator: British Columbia: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: Telephone

Category: Contact NumberShow more

Patient Services Site Aurinia Alliance™

2 hours ago Auriniaalliance.com Show details

833-287-4642Aurinia Alliance will contact you from this number 1-833-AURINIA (1-833-287-4642) I would like to receive information by text message (SMS) (optional) By providing us with your mobile number, you agree to receive text messages to this number from Aurinia or our automated dialer.

Category: Contact NumberShow more

Aurinia Compliance Program :: Aurinia Pharmaceuticals Inc

6 hours ago Auriniapharma.com Show details

A written copy of this declaration may be obtained by contacting our Compliance Department at [email protected] or calling Aurinia’s toll free number at 1-844-744- 2487. Please state that you are requesting a printed copy of Aurinia’s Annual Declaration of Compliance and provide your contact information, including your first name and

Category: Contact NumberShow more

Management Team :: Aurinia Pharmaceuticals Inc. (AUPH)

4 hours ago Auriniapharma.com Show details

Neil Solomons co-founded privately held Aurinia Pharmaceuticals in 2012. He is a seasoned pharmaceutical physician with 18 years of clinical development and medical affairs experience in both large pharma and biotech. He is a recognized expert in rare disease drug development and is widely published in this field.

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc (AUPH): Number 9, number 9

2 hours ago Investorshub.advfn.com Show details

SCWorx, Aurinia Pharmaceuticals leads healthcare gainers; Dicerna Pharmaceuticals, iCAD among major losers Seeking Alpha - 8/6/2021 11:02:32 AM: Aurinia Pharma extends gains following robust Q2 top-line growth Seeking Alpha - 8/6/2021 6:08:45 AM: Aurinia Pharma EPS misses by $0.01, beats on revenue Seeking Alpha - 8/5/2021 4:16:06 PM

Category: Contact NumberShow more

Aurinia Pharmaceuticals Wiki Finpedia

Just Now Finpedia.co Show details

Aurinia Pharmaceuticals Recent Development Aurinia (AUPH) is a clinical stage biopharmaceutical company with its head office located at #1203-4464 Markham Street, Victoria, British Columbia V8Z 7X8 where clinical, regulatory and business development functions of the …

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. Profile on TNet

Just Now Bctechnology.com Show details

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus

Category: Contact NumberShow more

Aurinia Pharmaceuticals, Inc. to Host Earnings Call

7 hours ago Finance.yahoo.com Show details

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) will be discussing their earnings results in their …

Category: Contact NumberShow more

Privacy Statement :: Aurinia Pharmaceuticals Inc. (AUPH)

7 hours ago Auriniapharma.com Show details

Personal Information contained in Customer records: such as physical characteristics or description, insurance policy number, bank account number, credit card number, debit card number, or any other financial information, please contact us at: Aurinia Pharmaceuticals Inc. …

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc (AUPH): Transcription of the

2 hours ago Investorshub.advfn.com Show details

SCWorx, Aurinia Pharmaceuticals leads healthcare gainers; Dicerna Pharmaceuticals, iCAD among major losers Seeking Alpha - 8/6/2021 11:02:32 AM: Aurinia Pharma extends gains following robust Q2 top-line growth Seeking Alpha - 8/6/2021 6:08:45 AM: Aurinia Pharma EPS misses by $0.01, beats on revenue Seeking Alpha - 8/5/2021 4:16:06 PM

Category: Contact NumberShow more

Investor Relations :: Aurinia Pharmaceuticals Inc. (AUPH)

9 hours ago Ir.auriniapharma.com Show details

514-982-7555Transfer Agent. Computershare Trust Company of Canada Shareholder Services Dept. 100 University Avenue 9th Floor Toronto, ON M5J 2Y1 Canada T: +1-514-982-7555

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc (AUPH) Company Profile & Facts

4 hours ago Finance.yahoo.com Show details

See the company profile for Aurinia Pharmaceuticals Inc (AUPH) including business summary, industry/sector information, number of employees, business summary, corporate governance, key …

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc Number of Employees 20142021

4 hours ago Macrotrends.net Show details

Aurinia Pharmaceuticals Inc number of employees from 2014 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc (AUPH): It is a conservative

2 hours ago Investorshub.advfn.com Show details

SCWorx, Aurinia Pharmaceuticals leads healthcare gainers; Dicerna Pharmaceuticals, iCAD among major losers Seeking Alpha - 8/6/2021 11:02:32 AM: Aurinia Pharma extends gains following robust Q2 top-line growth Seeking Alpha - 8/6/2021 6:08:45 AM: Aurinia Pharma EPS misses by $0.01, beats on revenue Seeking Alpha - 8/5/2021 4:16:06 PM

Category: Contact NumberShow more

FAQ :: Aurinia Pharmaceuticals Inc. (AUPH)

2 hours ago Ir.auriniapharma.com Show details

FAQ. When was Aurinia Pharmaceuticals founded? The company was incorporated in 1993 and its common shares have been listed in Canada since 1996. In September of 2013, the company acquired closely-held Aurinia Pharmaceuticals in an all stock transaction and subsequently adopted Aurinia Pharmaceuticals Inc. as its new corporate name.

Category: Contact NumberShow more

(AUPH) Understanding Aurinia Pharmaceuticals's Unusual

9 hours ago Benzinga.com Show details

Notable Aurinia Pharmaceuticals Insider Trades $2.92 Million In Company Stock The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug …

Category: Contact NumberShow more

Board Committees :: Aurinia Pharmaceuticals Inc. (AUPH)

5 hours ago Ir.auriniapharma.com Show details

Board Committees. Jill Leversage was appointed as an Independent Director of Aurinia in November 2019. Jill began her finance career at Burns Fry Ltd. and has held senior level positions at BMO Financial Group, RBC Capital Markets, and TD Securities. Jill has served on a number of public and not-for-profit corporate boards including MAG Silver

Category: Contact NumberShow more

BristolMyers Makes Takeover Approach to Aurinia

2 hours ago Bnnbloomberg.ca Show details

2 days ago · Aurinia rose 27% to close at $28.00 in New York on Friday, giving the company a market value of about $3.6 billion. A spokesperson for Bristol Myers said the company wouldn’t comment on rumors. A representative for Aurinia declined to comment. Formally known as Isotechnika Pharma, Aurinia specializes in therapies for severe autoimmune

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. (AUPH) 10K Annual Reports

6 hours ago Last10k.com Show details

Aurinia Pharmaceuticals Inc. Entity Incorporation, State or Country Code. Z4. Entity Tax Identification Number. 46-4129078. Entity Address, Address Line One. #1203-4464 Markham Street. Entity Address, City or Town. Victoria.

Category: Contact NumberShow more

What Do Analysts Think Of Aurinia Pharmaceuticals Inc

7 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 128.22 million. AUPH does have institutional investors; and they hold 44.90% of the stock. Aurinia Pharmaceuticals Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 8 new insider purchases involving 318,136 shares.

Category: Contact NumberShow more

Careers Aurinia Careers

1 hours ago Auriniacareers.com Show details

Please do not contact hiring managers directly. Aurinia Pharmaceuticals is an equal opportunity employer and considers qualified applicants for employment without regard to race, color, creed, religion, national origin, sex, sexual orientation, gender identity and expression, marital or civil partnership status, pregnancy, age, disability

Category: Contact NumberShow more

Patient Enrollment Form Aurinia Alliance

4 hours ago Auriniaalliance.com Show details

Aurinia would like to contact you regarding other programs and resources that may be of interest to you. By checking this box, I authorize Aurinia, to contact me by mail, email, fax, and/or telephone regarding other potential topics of interest to me, customer

Category: Contact NumberShow more

Aurinia Pharmaceuticals Announces Delisting from the

7 hours ago Finance.yahoo.com Show details

VICTORIA, British Columbia, July 16, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company), a commercial stage biopharmaceutical company advancing therapies for

Category: Contact NumberShow more

Notable Aurinia Pharmaceuticals Insider Trades $2.92

2 hours ago Finance.yahoo.com Show details

Martin still owns a total of 176,861 of Aurinia Pharmaceuticals worth, $3,616,807. Aurinia Pharmaceuticals shares are trading down 4.88% at $20.45 at the time of this writing on Wednesday morning

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call

8 hours ago Fool.com Show details

For the six months ended June 30, 2021, Aurinia recorded a net loss of $97.4 million or $0.76 per common share as compared to a net loss of $52.5 …

Category: Contact NumberShow more

AURINIA PHARMACEUTICALS INC. : Shareholders Board Members

5 hours ago Marketscreener.com Show details

Aurinia Pharmaceuticals Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases.

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. (AUPH) CEO John Leonard on Q2

4 hours ago Seekingalpha.com Show details

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President of Corporate Communications

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) insiders

4 hours ago Nasdaq.com Show details

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) value has fallen 11% in the last week, but insiders who sold US$32m worth of stock over the …

Category: Contact NumberShow more

What Are Analyst Opinions Regarding Aurinia

5 hours ago Baxterreport.com Show details

Aurinia Pharmaceuticals Inc. (AUPH) saw downtrend of -3.30% in the recent trading with $21.09 being its most recent. The current price level -12.78% lower than the highest price of $24.18 marked by the stock while trading over the past 52-weeks, whereas it is 116.98% higher than the lowest price of $9.72 the company dropped to over past 52-weeks.

Category: Contact NumberShow more

AUPH.O Aurinia Pharmaceuticals Inc News Reuters

5 hours ago Reuters.com Show details

BRIEF-Aurinia Pharmaceuticals Q1 Loss Per Share $0.15. * AURINIA REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS. a year ago. BRIEF-Aurinia Appoints Joe Miller As

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Receives

7 hours ago Marketbeat.com Show details

A number of hedge funds have recently modified their holdings of the stock. Diamond Hill Capital Management Inc. bought a new stake in Aurinia Pharmaceuticals during the 2nd quarter worth $239,000. Accel Wealth Management grew its position in Aurinia Pharmaceuticals by …

Category: Contact NumberShow more

Aurinia Pharmaceuticals (AUPH) surges 30% on talk of BMY

2 hours ago Tigerdroppings.com Show details

2 days ago · 1630 posts. Online. re: Aurinia Pharmaceuticals (AUPH) surges 30% on talk of BMY takeover! Posted. by Crescent Connection. on 10/7/21 at 11:35 am to castorinho. Stuck right at $20. Nice even number for buyout at $40, $50, or $60.

Category: Contact NumberShow more

Aurinia Pharmaceuticals to Present at Upcoming September

7 hours ago Investingnews.com Show details

Aurinia Pharmaceuticals Inc. today announced that members of the senior management team will present at the following upcoming virtual investor conferences: Oppenheimer Fall …

Category: Contact NumberShow more

Aurinia Pharmaceuticals (AUPH) surges 30% on talk of BMY

4 hours ago Tigerdroppings.com Show details

2 days ago · Old updates for posterity: And this one is not AS binary as many think: 31 October: Aurinia Announces Initiation of Patient Dosing in Phase 2/3 AUDREY™ Clinical Trial for Dry Eye Syndrome - Voclosporin ophthalmic solution (VOS) AUDREY trial results anticipated in the second half of 2020 – [quote]VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: …

Category: Contact NumberShow more

Aurinia Pharmaceuticals (AUPH) Page 90 TigerDroppings.com

8 hours ago Tigerdroppings.com Show details

re: Aurinia Pharmaceuticals (AUPH) Posted. by bayoubengals88. on 9/24/21 at 10:06 am to molsusports. quote: I'm not sure how vetted this information is but supposedly the prescription count for the third quarter continues to accumulate. 65 new scripts vs. 23 for Q2. These are only what can be seen via Bloomberg, but clearly, the trend looks great.

Category: Contact NumberShow more

Robert Huizinga, Executive Vice President, Corporate

2 hours ago Relationshipscience.com Show details

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Category: Contact NumberShow more

Managing Your Lupus Nephritis ALL IN for Lupus Nephritis

3 hours ago Allinforlupusnephritis.com Show details

Eating Well and Exercising with Lupus Nephritis. Maintaining a healthy lifestyle means eating the right kinds of foods and exercising as recommended by your doctor. As always, talk to your doctor before making any changes to your lifestyle, care, or diet. Get moving toward a healthier you. Diet and Exercise.

Category: Contact NumberShow more

Aurinia Pharmaceuticals Inc. (AUPH) Volatility Reaches 5

5 hours ago Stocksregister.com Show details

Having a second look at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) provides that stock’s average daily trading volume for 3 months was 4.17 million, while it jumped to 2.49 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 128.22 million. >> 7 Top Picks for the Post-Pandemic Economy

Category: Contact NumberShow more

$AUPH: New data is out now for Aurinia Pharmaceuticals Inc

8 hours ago Wallstreetfacts.com Show details

The 52-week high for Aurinia Pharmaceuticals Inc is $28 and the low is $9.72. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today

3 hours ago Fool.com Show details

Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) jumped by 26% during today's regular trading session. In Friday's after-hours session, however, the …

Category: Contact NumberShow more

Bristol Myers interested in buying Aurinia Pharma

5 hours ago Finance.yahoo.com Show details

2 days ago · Aurinia's shares closed up nearly 27% on the news, giving it a market capitalization of $3.59 billion, according to Refinitiv data. The report said no final decision has been made and that Bristol

Category: Contact NumberShow more

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today

1 hours ago Nasdaq.com Show details

021-10-232 days ago · To put this possible buyout number into context, Aurinia's market cap stood at roughly $3.6 billion at Friday's close. 10 stocks we like better than Aurinia Pharmaceuticals

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is Aurinia Pharmaceuticals Inc?

Aurinia is a global clinical stage biopharmaceutical company focused on developing and commercializing innovative products to treat serious diseases.

Who is the Chief Executive Officer of Aurinia?

Learn more about our leadership: Peter Greenleaf currently serves as the Chief Executive Officer and member of the Board of Directors of Aurinia. From March 2018 to April 2019, Peter served as the Chief Executive Officer of Cerecor, Inc.

What are the benefits of working for aurinia?

Aurinia offers benefits that promote the well-being of employees both personally and professionally. Aurinia provides a working environment where individuals can thrive in a professional, creative, and challenging environment. We are dedicated to our employees and our customers and thrive to constantly innovate to enhance the ever-changing market.

Who is Stephen Robertson, partner at Aurinia LLP?

Stephen Robertson brings more than 13 years of corporate law experience across various roles to Aurinia. Most recently he served as Partner with the law firm Borden Ladner Gervais LLP since 2014. He holds significant corporate legal experience across a number of industries including life sciences.

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes